4//SEC Filing
MUELLER PETER 4
Accession 0001104659-26-002979
CIK 0001720893other
Filed
Jan 11, 7:00 PM ET
Accepted
Jan 12, 7:06 PM ET
Size
5.7 KB
Accession
0001104659-26-002979
Insider Transaction Report
Form 4
MUELLER PETER
Director
Transactions
- Award
Stock Option (Right to Buy)
[F1]2026-01-09+17,000→ 17,000 totalExercise: $2.01Exp: 2036-01-09→ Common Stock (17,000 underlying)
Footnotes (1)
- [F1]The option shall vest and become exercisable on the earlier of the first anniversary of the date of grant or the day immediately prior to the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant, in either case, subject to the Reporting Person's continuing in service as a non-employee director through such vesting date.
Signature
/s/ Richard Steinhart, Attorney-in-Fact for Peter Mueller|2026-01-12
Documents
Issuer
BioXcel Therapeutics, Inc.
CIK 0001720893
Entity typeother
Related Parties
1- filerCIK 0001256126
Filing Metadata
- Form type
- 4
- Filed
- Jan 11, 7:00 PM ET
- Accepted
- Jan 12, 7:06 PM ET
- Size
- 5.7 KB